Anti-CD11a (Efalizumab), Human IgG1 Antibody

Anti-CD11a (Efalizumab), Human IgG1 Antibodyis available at Gentaur for Next week Delivery.

Description: Integrin alpha-L/beta-2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4. It is involved in a variety of immune phenomena including leukocyte-endothelial cell interaction, cytotoxic T-cell mediated killing, and antibody dependent killing by granulocytes and monocytes.

Immunogen Sequence:Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.

Target Alternative Name:LFA-1; integrin alpha L

Species Reactivities:Human

Tag Line:Monoclonal antibody to detect CD11a in human samples.

Formulation:200 µg affinity purified human antibody in phosphate-buffered saline (PBS) containing 0.02% Proclin 300

Purification: Affinity purified using protein A

Application:/

Positive Control:N/A

Application And Usages:/

Handling:The antibody solution should be gently mixed before use